In conclusion, circulating IGF1 and IGFBP3 levels were positively associated with the incidence of HCC, and the IGF1 level emerged as an independent prognostic factor for the progression and survival of HCC patients. The gene discussed is IGF1; the disease is hepatocellular carcinoma.